Eagle Pharmaceuticals, Inc. Dilutive Share Adjustment
Eagle Pharmaceuticals, Inc. reported Dilutive Share Adjustment of 13.08 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2021-11-09
- Eagle Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2021-09-30 was 13.08M shares, a 5.15% decline year-over-year.
- Eagle Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2021-06-30 was 13.26M shares, a 2.95% decline year-over-year.
- Eagle Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2021-03-31 was 13.07M shares, a 4.38% decline year-over-year.
- Eagle Pharmaceuticals, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2020-09-30 was 13.79M shares, a 0.87% increase year-over-year.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month |
|---|---|---|---|
| 2021-09-30 | 13.08M shares 10-Q · filed 2021-11-09 | 13.17M shares derived: average of 2 quarters · filed 2021-11-09 | 13.10M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 13.26M shares 10-Q · filed 2021-08-09 | 13.29M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 13.07M shares 10-Q · filed 2021-05-10 | ||
| 2020-09-30 | 13.79M shares 10-Q · filed 2021-11-09 | 13.73M shares derived: average of 2 quarters · filed 2021-11-09 | 13.92M shares 10-Q · filed 2021-11-09 |
| 2020-06-30 | 13.66M shares 10-Q · filed 2021-08-09 | 13.67M shares 10-Q · filed 2021-08-09 | |
| 2020-03-31 | 13.67M shares 10-Q · filed 2021-05-10 | ||
| 2019-09-30 | 13.67M shares 10-Q · filed 2020-11-02 | 13.91M shares derived: average of 2 quarters · filed 2020-11-02 | 14.15M shares 10-Q · filed 2020-11-02 |
| 2019-06-30 | 14.16M shares 10-Q · filed 2020-08-10 | 14.18M shares 10-Q · filed 2020-08-10 | |
| 2019-03-31 | 14.42M shares 10-Q · filed 2020-05-11 | ||
| 2018-09-30 | 15.48M shares 10-Q · filed 2019-11-12 | 15.46M shares derived: average of 2 quarters · filed 2019-11-12 | 15.48M shares 10-Q · filed 2019-11-12 |
| 2018-06-30 | 15.45M shares 10-Q · filed 2019-08-08 | 15.47M shares 10-Q · filed 2019-08-08 | |
| 2018-03-31 | 15.48M shares 10-Q · filed 2019-05-07 | ||
| 2017-09-30 | 15.76M shares 10-Q · filed 2018-11-01 | 15.93M shares derived: average of 2 quarters · filed 2018-11-01 | 16.02M shares 10-Q · filed 2018-11-01 |
| 2017-06-30 | 16.10M shares 10-Q · filed 2018-08-07 | 16.14M shares 10-Q · filed 2018-08-07 | |
| 2017-03-31 | 16.17M shares 10-Q · filed 2018-05-10 | ||
| 2016-09-30 | 16.45M shares 10-Q · filed 2017-11-08 | 16.46M shares derived: average of 2 quarters · filed 2017-11-08 | 16.50M shares 10-Q · filed 2017-11-08 |
| 2016-06-30 | 16.47M shares 10-Q · filed 2017-08-09 | 16.53M shares 10-Q · filed 2017-08-09 | |
| 2016-03-31 | 15.64M shares 10-Q · filed 2017-05-08 | ||
| 2015-09-30 | 15.59M shares 10-Q · filed 2016-11-09 | 15.57M shares derived: average of 2 quarters · filed 2016-11-09 | 16.12M shares 10-Q · filed 2016-11-09 |
| 2015-06-30 | 15.55M shares 10-Q · filed 2016-08-09 | 15.88M shares 10-Q · filed 2016-08-09 | |
| 2015-03-31 | 15.04M shares 10-Q · filed 2016-05-10 | ||
| 2014-09-30 | 14.02M shares 10-Q · filed 2015-11-12 | 14.02M shares derived: average of 2 quarters · filed 2015-11-12 | 12.32M shares 10-Q · filed 2015-11-12 |
| 2014-06-30 | 14.02M shares 10-Q · filed 2015-08-11 | 11.46M shares 10-Q · filed 2015-08-11 | |
| 2014-03-31 | 8.86M shares 10-Q · filed 2015-05-15 |